KRAS and cancer: These observations support the findings of Mohan et al. where somatic KRAS mutations were observed in 25% of locally advanced disease using ddPCR; however, the detection rate was substantially increased through NGS analysis of an additional 640 cancer associated genes to 50% in locally advanced disease [28].